{"id":"https://openalex.org/W2373366407","doi":null,"title":"Research progress of xanthine oxidoreductase in biological functions and its inhibitor development","display_name":"Research progress of xanthine oxidoreductase in biological functions and its inhibitor development","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2373366407","mag":"2373366407"},"language":"en","primary_location":{"id":"mag:2373366407","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-YLZL200610000.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764721185","display_name":"Zhongguo linchuang yaolixue yu zhiliaoxue","issn_l":"1009-2501","issn":["1009-2501"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4361727491","host_organization_name":"Chinese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4361727491"],"host_organization_lineage_names":["Chinese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo linchuang yaolixue yu zhiliaoxue","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109301780","display_name":"Shen-Yin Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Shen-Yin Zhu","raw_affiliation_strings":["2 Institute of Materia Medica, Chinese Academy of Medical Science, Beijing 100050, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2 Institute of Materia Medica, Chinese Academy of Medical Science, Beijing 100050, China","institution_ids":["https://openalex.org/I200296433"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109301780"],"corresponding_institution_ids":["https://openalex.org/I200296433"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.3105787,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/xanthine-oxidoreductase","display_name":"xanthine oxidoreductase","score":0.9990000128746033},{"id":"https://openalex.org/keywords/molybdenum-enzymes","display_name":"molybdenum enzymes","score":0.8569999933242798},{"id":"https://openalex.org/keywords/purine-metabolism","display_name":"purine metabolism","score":0.9559999704360962},{"id":"https://openalex.org/keywords/uric-acid","display_name":"uric acid","score":0.8050000071525574},{"id":"https://openalex.org/keywords/hyperuricemia","display_name":"hyperuricemia","score":0.7990000247955322},{"id":"https://openalex.org/keywords/gout","display_name":"gout","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ischemia-reperfusion-injury","display_name":"ischemia-reperfusion injury","score":0.9750000238418579},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.9929999709129333},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.9869999885559082},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cardiovascular-drug-development","display_name":"cardiovascular drug development","score":0.7080000042915344}],"concepts":[{"id":"https://openalex.org/C2781116151","wikidata":"https://www.wikidata.org/wiki/Q410305","display_name":"Hypoxanthine","level":3,"score":0.758070707321167},{"id":"https://openalex.org/C2776476023","wikidata":"https://www.wikidata.org/wiki/Q188261","display_name":"Purine","level":3,"score":0.712864875793457},{"id":"https://openalex.org/C2780932893","wikidata":"https://www.wikidata.org/wiki/Q417296","display_name":"Febuxostat","level":4,"score":0.697521984577179},{"id":"https://openalex.org/C2779881121","wikidata":"https://www.wikidata.org/wiki/Q105522","display_name":"Uric acid","level":2,"score":0.6900206208229065},{"id":"https://openalex.org/C2779470414","wikidata":"https://www.wikidata.org/wiki/Q50980","display_name":"Xanthine","level":3,"score":0.6472033262252808},{"id":"https://openalex.org/C2780972559","wikidata":"https://www.wikidata.org/wiki/Q550061","display_name":"Endothelial dysfunction","level":2,"score":0.5309032201766968},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.529419481754303},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4819357395172119},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.4601787328720093},{"id":"https://openalex.org/C2780591200","wikidata":"https://www.wikidata.org/wiki/Q412534","display_name":"Carvedilol","level":3,"score":0.4482616186141968},{"id":"https://openalex.org/C2780402116","wikidata":"https://www.wikidata.org/wiki/Q133087","display_name":"Gout","level":2,"score":0.44604694843292236},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.42986056208610535},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3796638250350952},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.26947879791259766},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25233781337738037},{"id":"https://openalex.org/C2779721657","wikidata":"https://www.wikidata.org/wiki/Q49970","display_name":"Hyperuricemia","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2373366407","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-YLZL200610000.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764721185","display_name":"Zhongguo linchuang yaolixue yu zhiliaoxue","issn_l":"1009-2501","issn":["1009-2501"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4361727491","host_organization_name":"Chinese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4361727491"],"host_organization_lineage_names":["Chinese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo linchuang yaolixue yu zhiliaoxue","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1953423403","https://openalex.org/W2018008275","https://openalex.org/W7098551305","https://openalex.org/W2014886061","https://openalex.org/W293796396","https://openalex.org/W2073007450","https://openalex.org/W7128501389","https://openalex.org/W3217596580","https://openalex.org/W3125249206","https://openalex.org/W1970003951"],"abstract_inverted_index":{"xanthine":[0,21],"oxidoreductase(XOR)is":[1],"a":[2],"member":[3],"of":[4,28,41,95],"the":[5,39,45,74,92,99],"molybdoenzyme":[6],"family":[7],"and":[8,20,30,43,70],"best":[9],"known":[10],"for":[11,47],"its":[12,36],"catalytic":[13],"role":[14,37,46],"in":[15,38,55,66,80,86,98],"purine":[16,50],"degradation,":[17],"metabolizing":[18],"hypoxanthine":[19],"to":[22,35,91],"uric":[23],"acid":[24],"with":[25],"concomitant":[26],"generation":[27],"superoxide":[29],"hydrogen":[31],"peroxide.":[32],"In":[33],"addition":[34],"pathophysiology":[40],"hyperuricaemia":[42],"gout,":[44],"XOR":[48,75,85,96,107],"beyond":[49],"metabolism":[51],"was":[52],"first":[53],"suggested":[54],"ischaemia-reperfusion":[56],"injury,":[57],"there":[58],"is":[59],"growing":[60],"evidence":[61],"that":[62],"it":[63],"also":[64],"participates":[65],"endothelial":[67],"dysfunction,":[68],"hypertension":[69],"heart":[71,81],"failure.":[72],"Importantly,":[73],"inhibitor":[76],"attenuates":[77],"dysfunction":[78],"especially":[79],"failure":[82],"caused":[83],"by":[84,110],"these":[87],"disease":[88],"states.":[89],"Attention":[90],"broader":[93],"range":[94],"bioactivity":[97],"cardiovascular":[100],"system":[101],"has":[102],"prompted":[103],"strong":[104],"interest":[105],"based":[106],"drug":[108],"development":[109],"pharmaceuticals":[111],"company.":[112]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}